Get started
Author

Ant Uzay

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
2021 · Robert Zeiser, Nicola Polverelli, et al. · New England Journal of Medicine · 528
PDF
Human herpes virus 8‐unrelated primary effusion lymphoma‐like lymphoma: report of a rare case and review of the literature
2009 · CAFER ADIGUZEL, SUHEYLA UYAR BOZKURT, et al. · Apmis · 59
Bortezomib: a new therapeutic option for POEMS syndrome
2009 · Isik Kaygusuz, Hakan Tezcan, et al. · European Journal Of Haematology · 54
PDF
Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data
2023 · Elif Birtas Atesoglu, Zafer Gulbas, et al. · Hematological Oncology · 34
PDF
Effects of neuromuscular electrical stimulation combined with resistance exercises on muscle strength in adult hematological cancer patients: A randomized controlled study
2022 · Elif Esma Safran, Fatma Mutluay, et al. · Leukemia Research · 21
Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study
2021 · Olga Meltem Akay, Murat Ozbalak, et al. · Hematological Oncology · 21
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study
2025 · Robert Zeiser, Domenico Russo, et al. · Journal of Clinical Oncology · 18
Synchronous renal cell carcinoma and multiple myeloma: report of two cases and review of the literature.
2010 · M A Ozturk, F Dane, et al. · PubMed · 18
Bortezomib in patients with renal impairment
2011 · Isik Kaygusuz, Tayfur Toptas, et al. · Hematology · 14
PDF
Myelodysplastic syndrome with t(9;22)(p24;q11.2), a BCR-JAK2 fusion: case report and review of the literature
2015 · Bulent Kantarcioglu, Isik Kaygusuz-Atagunduz, et al. · International Journal of Hematology · 13
Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey
2022 · Mehmet Sinan Dal, Bahar Uncu Ulu, et al. · Annals of Hematology · 12
PDF
Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data
2022 · Burhan Ferhanoglu, Zafer Gulbas, et al. · Blood · 9
Daily low dose intravesical cidofovir for the treatment of BK virus associated hemorrhagic cystitis after allogeneic stem cell transplantation
2022 · Ant Uzay, Yasemin Gündoğdu, et al. · Journal of Infection and Chemotherapy · 9
Rh (D) alloimmunization treated by double filtration plasmapheresis
2018 · Sibel Gokcay Bek, Necmi Eren, et al. · Transfusion and Apheresis Science · 7
The Prognostic Value of CD49d Expression in Turkish Patients with Chronic Lymphocytic Leukemia
2012 · Ant Uzay, Tayfur Toptas, et al. · Turkish Journal of Hematology · 6
PDF
Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study
2023 · Robert Zeiser, Domenico Russo, et al. · Blood · 5
Successful Preoperative Treatment with Plasmapheresis of Patients with Hyperthyroidism
2018 · Şeyma BAHSİ, Nigar RUSTEMOVA, et al. · Endocrinology research and practice. · 3
PDF
Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center
2024 · Ant Uzay, Yasemin Gündoğdu, et al. · Cancer Medicine · 2
Fusariosis manifesting as targetoid purpuric cutaneous lesions in immunocompromised patients
2020 · Y. Erdemoglu, I.E. Aydingoz, et al. · Journal of the European Academy of Dermatology and Venereology · 2
Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease
2020 · Osman Ilhan, Guldane Cengiz Seval, et al. · Transplantation and Cellular Therapy · 2
Does it take three to tango? An unsuspected multimorbidity of CD8+ T cell lymphoproliferative disorder, malaria, and EBV infection
2018 · Suheyla Ekemen, Ant Uzay, et al. · Malaria Journal · 2
The prognostic value of CD49d expression in Turkish patients with chronic lymphocytic leukemia
2012 · Ant Uzay, Tayfur Toptas, et al. · Turkish Journal of Hematology · 2
PDF
Elranatamab in Heavily Pretreated Triple-class Refractory Multiple Myeloma: A Single-center Experience
2025 · Ant Uzay · Acta haematologica oncologica Turcica. · 1
PDF
A comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma
2025 · Abdullah Karakus, Ugur Hatipoglu, et al. · Transfusion and Apheresis Science · 1
The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes
2025 · Burcu Aslan Candir, Nazik Okumus, et al. · Transfusion and Apheresis Science · 1
Works count: 56
Citation count: 845
H-index: 11
I10-index: 11
Year
Topic
Type